Pharma

Your Article Summary

See Latest Articles

NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder
Nucryst, 12/03/08

NUCRYST Pharmaceuticals Corp., a developer and manufacturer of medical products that fight infection and inflammation, announced that its Board of Directors has received from its majority shareholder, The Westaim Corporation ("Westaim"), a requisition to call a special meeting of shareholders to consider a return of capital of US$0.80 per share to NUCRYST shareholders. This equates to a return of capital of approximately US$15 million. The special meeting requisition also requests that shareholders set the number of directors of NUCRYST and elect directors.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Report: Acquisition Activity Down
HealthDataManagement, 12/08/09

Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 12/07/09

Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09

 See all of Financial Reports